2024
DOI: 10.4014/jmb.2312.12031
|View full text |Cite
|
Sign up to set email alerts
|

Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome

Yu-Rim Chae,
Yu Ra Lee,
Young-Soo Kim
et al.

Abstract: Chronic gut inflammation promotes the development of metabolic diseases such as obesity. There is growing evidence which suggests that dysbiosis in gut microbiota and metabolites disrupt the integrity of the intestinal barrier and significantly impact the level of inflammation in various tissues, including the liver and adipose tissues. Moreover, dietary sources are connected to the development of leaky gut syndrome through their interaction with the gut microbiota. This review examines the effects of these fa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 108 publications
0
2
0
Order By: Relevance
“…Consequently, the liver serves as the primary line of defense against endotoxins produced by the intestinal tract. Changes in intestinal microbiota, such as the aforementioned leaky gut syndrome, can thus contribute to the development of MAFLD [114][115][116]. In parallel, metabolic dysregulations produced by pathologies such as MAFLD exacerbate both intrahepatic and systemic pro-inflammatory conditions, heightening the risk of neurodegeneration associated with hepatic encephalopathy.…”
Section: Brain-gut-liver Axismentioning
confidence: 99%
“…Consequently, the liver serves as the primary line of defense against endotoxins produced by the intestinal tract. Changes in intestinal microbiota, such as the aforementioned leaky gut syndrome, can thus contribute to the development of MAFLD [114][115][116]. In parallel, metabolic dysregulations produced by pathologies such as MAFLD exacerbate both intrahepatic and systemic pro-inflammatory conditions, heightening the risk of neurodegeneration associated with hepatic encephalopathy.…”
Section: Brain-gut-liver Axismentioning
confidence: 99%
“…The human gastrointestinal tract harbors trillions of symbiotic bacterial species, collectively termed gut microbiota, which provide numerous health benefits when adequate microbial diversity and abundance are achieved [11,12]. However, in states of dysbiosis, changes in the composition profile of gut microbiota and its metabolic byproducts can contribute to the onset of pathogenic conditions [13,14]. There are six main phyla of gut bacteria that include Firmicutes, Bacteroidetes, Verrucomicrobia, Actinobacteria, Euryarchaeota, and Proteobacteria, with over 90% of the total composition being composed of Firmicutes and Bacteroidetes [15].…”
Section: Introductionmentioning
confidence: 99%